Switching Language

Please note that your current login session is only valid on the English site (letpub.com). You will not be signed in on other language versions of the site. If you wish to place an order, please return to the English site.

    Research Creative   My Account   Submit My Manuscript
Letpub, Scientific Editing Services, Manuscript Editing Service


Scientific Journal Selector



New Free Tool: Verity — Pre-Submission Manuscript Check
Automatically checks your manuscript across 34 criteria including structure, metadata, disclosures, and language issues before you submit to your target journal.
Try for Free →
  
  
-

Expert Review of Anticancer Therapy


👁  22033 View(s)

 16 Review(s)  

 Open Access      SCIE      Official Website     Submission Website
 

*Average Peer Review
Sort of slow, 4-8 Week(s)
*Competitiveness
Easy
CiteScore
4.9

CiteScore Rank
Subject Area Rank Percentile
Category: Medicine
Subcategory: Pharmacology (medical)
103 / 278
Category: Medicine
Subcategory: Oncology
162 / 428



Country/Area of Publication
ENGLAND
Publication Frequency
Bimonthly
Publisher
Taylor and Francis Ltd.

ISSN
1473-7140
E-ISSN
1744-8328
Year Publication Started
2001

Self-citation (2025-2026)
3.30%
Annual Article Volume
164
Gold OA Percentage
2.11%


Open Access Info
APC APC Waiver Other Charges
N/A N/A N/A

Journal Aim & Scope
Expert Review of Anticancer Therapy (ISSN 1473-7140) provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches.

Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological therapy, cancer vaccines, therapeutic indications, biomarkers and diagnostics, and treatment guidelines. All articles are subject to rigorous peer-review, and the journal makes an essential contribution to decision-making in cancer care.

Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections:


Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results

Article Highlights – an executive summary of the author’s most critical points.


Web of Science Quartiles
WOS Quartile: Q3

Quartiles By JIFCollectionQuartileRankPercentage
Category: ONCOLOGYSCIEQ3172/333
Quartiles By JCICollectionQuartileRankPercentage
Category: ONCOLOGYSCIEQ3242/333
*Crowdsourced data
  • Journals In The Same Subject Area
  • CiteScore Trends
  • Self Citation Trends
  • Annual Article Volume Trends
  • Journal Title h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144649.80
    Nature Reviews Clinical Oncology127126.60
    ANNALS OF ONCOLOGY21069.60
    NATURE REVIEWS CANCER39696.20
    CANCER CELL29575.40
    JOURNAL OF CLINICAL ONCOLOGY49414.20
    LANCET ONCOLOGY27442.00
    CANCER RESEARCH41117.00
    SEMINARS IN CANCER BIOLOGY13442.00
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH6722.30
  • Expert Review of Anticancer Therapy Expert Review of Anticancer Therapy
    Predict CiteScore Trend:
    Steady Increase No Change Gradual Decline  Refresh
 
    👁  22033 View(s)
    ☰  Review(s)        
 
 
 

Select your rating and start your review of Expert Review of Anticancer Therapy

 

    Journals In The Same Field
    CA-A CANCER JOURNAL FOR CLINICIANS
    CiteScore: 649.80

    NATURE REVIEWS DRUG DISCOVERY
    CiteScore: 159.20

    MMWR Recommendations and Reports
    CiteScore: 131.20

    Nature Reviews Clinical Oncology
    CiteScore: 126.60

    Kidney International Supplements
    CiteScore: 117.70

    NATURE REVIEWS CANCER
    CiteScore: 96.20

    MMWR Surveillance Summaries
    CiteScore: 93.20

    LANCET
    CiteScore: 92.40

    World Psychiatry
    CiteScore: 84.80

    World Psychiatry
    CiteScore: 84.80



    © 2010-2026  ACCDON LLC 400 5th Ave, Suite 530, Waltham, MA 02451, USA
    Privacy • Terms of Servic